Bluejay Diagnostics (BJDX) Competitors $1.66 -0.11 (-6.21%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$1.65 -0.01 (-0.60%) As of 06/13/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BJDX vs. PAVM, SSKN, INBS, LUCY, NURO, CODX, STRR, POAI, TNON, and IINNShould you be buying Bluejay Diagnostics stock or one of its competitors? The main competitors of Bluejay Diagnostics include PAVmed (PAVM), STRATA Skin Sciences (SSKN), Intelligent Bio Solutions (INBS), Innovative Eyewear (LUCY), NeuroMetrix (NURO), Co-Diagnostics (CODX), Star Equity (STRR), Predictive Oncology (POAI), Tenon Medical (TNON), and Inspira Technologies Oxy B.H.N. (IINN). These companies are all part of the "medical equipment" industry. Bluejay Diagnostics vs. Its Competitors PAVmed STRATA Skin Sciences Intelligent Bio Solutions Innovative Eyewear NeuroMetrix Co-Diagnostics Star Equity Predictive Oncology Tenon Medical Inspira Technologies Oxy B.H.N. PAVmed (NASDAQ:PAVM) and Bluejay Diagnostics (NASDAQ:BJDX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, community ranking, dividends, media sentiment, institutional ownership, profitability, valuation and earnings. Is PAVM or BJDX more profitable? PAVmed has a net margin of 602.97% compared to Bluejay Diagnostics' net margin of 0.00%. PAVmed's return on equity of 0.00% beat Bluejay Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets PAVmed602.97% N/A -92.36% Bluejay Diagnostics N/A -155.67%-117.82% Which has more risk and volatility, PAVM or BJDX? PAVmed has a beta of 1.06, indicating that its stock price is 6% more volatile than the S&P 500. Comparatively, Bluejay Diagnostics has a beta of 0.38, indicating that its stock price is 62% less volatile than the S&P 500. Do analysts rate PAVM or BJDX? PAVmed presently has a consensus target price of $19.00, indicating a potential upside of 2,875.72%. Given PAVmed's stronger consensus rating and higher probable upside, equities analysts clearly believe PAVmed is more favorable than Bluejay Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PAVmed 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Bluejay Diagnostics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community prefer PAVM or BJDX? PAVmed received 203 more outperform votes than Bluejay Diagnostics when rated by MarketBeat users. However, 66.67% of users gave Bluejay Diagnostics an outperform vote while only 66.34% of users gave PAVmed an outperform vote. CompanyUnderperformOutperformPAVmedOutperform Votes20566.34% Underperform Votes10433.66% Bluejay DiagnosticsOutperform Votes266.67% Underperform Votes133.33% Do institutionals & insiders have more ownership in PAVM or BJDX? 19.9% of PAVmed shares are held by institutional investors. Comparatively, 18.5% of Bluejay Diagnostics shares are held by institutional investors. 7.3% of PAVmed shares are held by insiders. Comparatively, 0.1% of Bluejay Diagnostics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has better valuation & earnings, PAVM or BJDX? Bluejay Diagnostics has lower revenue, but higher earnings than PAVmed. Bluejay Diagnostics is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPAVmed$1.99M5.48-$64.18M$0.710.90Bluejay Diagnostics$250K9.92-$9.95M-$379.740.00 Does the media favor PAVM or BJDX? In the previous week, PAVmed had 1 more articles in the media than Bluejay Diagnostics. MarketBeat recorded 3 mentions for PAVmed and 2 mentions for Bluejay Diagnostics. Bluejay Diagnostics' average media sentiment score of 1.43 beat PAVmed's score of 0.28 indicating that Bluejay Diagnostics is being referred to more favorably in the news media. Company Overall Sentiment PAVmed Neutral Bluejay Diagnostics Positive SummaryPAVmed beats Bluejay Diagnostics on 13 of the 18 factors compared between the two stocks. Get Bluejay Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for BJDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BJDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BJDX vs. The Competition Export to ExcelMetricBluejay DiagnosticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.48M$4.32B$5.57B$8.50BDividend YieldN/A42.67%5.28%4.16%P/E Ratio0.0027.8226.6319.64Price / Sales9.9268.18407.99152.17Price / CashN/A51.0838.2534.64Price / Book0.005.746.964.60Net Income-$9.95M$66.95M$3.23B$248.06M7 Day Performance-26.22%-2.90%-1.13%-0.94%1 Month Performance-2.92%16.02%8.59%3.52%1 Year Performance-99.19%18.20%33.63%14.02% Bluejay Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BJDXBluejay Diagnostics1.3403 of 5 stars$1.66-6.2%N/A-99.1%$2.48M$250K0.009Positive NewsShort Interest ↓Gap DownPAVMPAVmed3.8882 of 5 stars$0.61+1.5%$19.50+3,096.7%-42.5%$10.43M$1.99M-0.1490SSKNSTRATA Skin Sciences2.8369 of 5 stars$2.45+0.9%$6.00+144.8%-25.7%$10.22M$33.62M-0.92120Short Interest ↑Gap UpINBSIntelligent Bio Solutions0.4777 of 5 stars$1.43+1.4%N/A-11.6%$9.88M$2.94M0.0010Positive NewsGap DownLUCYInnovative Eyewear0.8813 of 5 stars$3.12-2.2%N/A-72.2%$9.66M$1.71M-0.329Analyst UpgradeShort Interest ↓NURONeuroMetrixN/A$4.55+4.4%N/A+22.3%$9.37M$3.03M-0.9920High Trading VolumeCODXCo-Diagnostics4.1324 of 5 stars$0.26+2.2%$5.50+2,005.7%-83.7%$8.77M$3.71M-0.19100Short Interest ↑STRRStar Equity2.824 of 5 stars$2.67+12.2%$5.00+87.3%-51.2%$8.57M$57.17M-1.04460Short Interest ↑Gap UpHigh Trading VolumePOAIPredictive Oncology1.9689 of 5 stars$0.95+7.9%$3.00+215.8%-23.8%$8.49M$1.73M-0.3130News CoverageShort Interest ↑TNONTenon Medical2.8124 of 5 stars$1.08flat$4.67+332.1%+43.1%$8.20M$3.28M-0.048News CoveragePositive NewsShort Interest ↓IINNInspira Technologies Oxy B.H.N.2.2366 of 5 stars$0.62+2.1%$2.00+221.0%-62.8%$7.86MN/A0.0020Short Interest ↑ Related Companies and Tools Related Companies PAVmed Alternatives STRATA Skin Sciences Alternatives Intelligent Bio Solutions Alternatives Innovative Eyewear Alternatives NeuroMetrix Alternatives Co-Diagnostics Alternatives Star Equity Alternatives Predictive Oncology Alternatives Tenon Medical Alternatives Inspira Technologies Oxy B.H.N. Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BJDX) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bluejay Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bluejay Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
